BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05012371-completion@plaintrial.com
DTSTAMP:20260926T170548Z
DTSTART;VALUE=DATE:20271025
SUMMARY:Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or T
 hird-Line Treatment of Metastatic Renal Cell Cancer — estimated completi
 on date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05012371
URL:https://plaintrial.com/trial/NCT05012371
END:VEVENT
END:VCALENDAR